Invivo Therapeutics Holding Corp., of Cambridge, Mass., reported that it has initiated a proposed public offering of its common stock, to be valued at $0.00001 per share. H.C. Wainwright & Co. is serving as exclusive placement agent.
Burlington, N.C.-based Laboratory Corp. of America Holdings, commonly known as Labcorp, has launched a cash tender offer to buy up to $300 million principal amount of its outstanding $600 million aggregate principal amount of 4.625% senior notes due in 2020. The offer is restricted to holder of the notes under a Nov. 18, 2019, offer to purchase, which expires Dec. 16, 2019. In addition, Labcorp said it plans to offer senior notes and to issue them in two tranches. Proceeds from the sale will be used to purchase, redeem or repay at maturity 2.625% senior notes due Feb. 1, 2020, buy up to $300 million of 4.625% senior notes, due Nov. 15, 2020, in a concurrent tender offer, and repay some or all of the company's outstanding debt.
Neurometrix Inc., of Woburn, Mass., reported a one-for-10 reverse split of its common stock aimed at satisfying the $1 minimum bid price requirement for continued listing on the Nasdaq Capital Market. Shares of the company's common stock and certain warrants will begin trading on a split-adjusted basis on Nov. 19, 2019, under the new CUSIP number 641255807.